Eli Lilly Announces Impressive Fourth-Quarter Dividend Plan
The board of directors of Eli Lilly and Company (NYSE: LLY) has made a significant announcement regarding the fourth-quarter dividend for 2024. The declared dividend stands at $1.30 per share for its outstanding common stock. This move reflects Lilly's dedication to its shareholders and the continuous evolution in its business strategies.
Details of the Upcoming Dividend
The dividend payment is set to take place on a designated date in December, provided the shareholders are recorded by mid-November. This systematic approach in dividend distribution aligns with Lilly's established practices, ensuring that its shareholders receive consistent returns as appreciation of their investment in the company.
About Eli Lilly and Company
Eli Lilly prides itself on being a front-runner in the pharmaceutical industry, particularly known for turning scientific innovations into therapeutic solutions that improve lives globally. With a legacy of nearly 150 years, the company is committed to addressing critical health challenges with groundbreaking discoveries that include redefining diabetes treatment, tackling obesity, and advancing therapies for Alzheimer's disease. Additionally, Lilly focuses on innovative solutions for immune system disorders and developing treatments for challenging cancers.
Commitment to Accessibility and Diversity
Lilly emphasizes not only innovation in medicine but also ensuring accessibility and affordability for the diverse communities it serves. The company actively engages in clinical trials that reflect this diversity, aiming for broad participation and benefit.
Financial Performance and Future Outlook
As the company moves into the fourth quarter, its strong financial performance is underlined by this dividend declaration. Lilly's ability to maintain a substantial dividend even in changing economic conditions speaks volumes about its operational resilience and future growth prospects. Investors can look forward to the company's continued efforts in advancing health solutions and expanding its market reach, which could result in potential increases in shareholder value.
Cultivating Innovation Continues
While maintaining its focus on investor returns, Lilly is equally committed to fostering an innovative environment that drives its research and development forward. The company is keen on exploring new technologies and novel approaches in biotechnology and genetic medicine to address pressing health issues and enhance patient outcomes.
Frequently Asked Questions
What is the amount declared for the fourth-quarter dividend by Eli Lilly?
The company has declared a dividend of $1.30 per share for the fourth quarter of 2024.
When will the dividend be paid to shareholders?
The dividend is scheduled to be paid in December 2024 to shareholders of record by mid-November 2024.
How long has Eli Lilly been in operation?
Eli Lilly has been pioneering discoveries in the pharmaceutical industry for nearly 150 years.
What health challenges does Eli Lilly focus on?
Lilly targets significant health challenges, including diabetes care, obesity, Alzheimer's disease, immune disorders, and difficult-to-treat cancers.
How does Lilly ensure the accessibility of its medicines?
Lilly is committed to delivering affordable healthcare solutions and involves a diverse range of communities in its clinical trials to ensure broad access.
